HK1211980A1 - Multifunctional oral vaccine based on chromosome recombineering - Google Patents

Multifunctional oral vaccine based on chromosome recombineering Download PDF

Info

Publication number
HK1211980A1
HK1211980A1 HK15112845.5A HK15112845A HK1211980A1 HK 1211980 A1 HK1211980 A1 HK 1211980A1 HK 15112845 A HK15112845 A HK 15112845A HK 1211980 A1 HK1211980 A1 HK 1211980A1
Authority
HK
Hong Kong
Prior art keywords
recombineering
chromosome
vaccine based
oral vaccine
multifunctional oral
Prior art date
Application number
HK15112845.5A
Other languages
English (en)
Chinese (zh)
Inventor
Madushini Nirosha DHARMASENA
Dennis J. Kopecko
Original Assignee
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The United States Of America, As Represented By The Secretary, Department Of Health & Human Services filed Critical The United States Of America, As Represented By The Secretary, Department Of Health & Human Services
Publication of HK1211980A1 publication Critical patent/HK1211980A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0283—Shigella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/25—Shigella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15112845.5A 2012-09-17 2013-09-16 Multifunctional oral vaccine based on chromosome recombineering HK1211980A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261701939P 2012-09-17 2012-09-17
US201261701939P 2012-09-17
PCT/US2013/059980 WO2014043637A1 (en) 2012-09-17 2013-09-16 Multifunctional oral vaccine based on chromosome recombineering

Publications (1)

Publication Number Publication Date
HK1211980A1 true HK1211980A1 (en) 2016-06-03

Family

ID=50278754

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15112845.5A HK1211980A1 (en) 2012-09-17 2013-09-16 Multifunctional oral vaccine based on chromosome recombineering

Country Status (9)

Country Link
US (1) US9750793B2 (cg-RX-API-DMAC10.html)
EP (1) EP2895596A4 (cg-RX-API-DMAC10.html)
JP (1) JP2015533491A (cg-RX-API-DMAC10.html)
KR (1) KR20150058435A (cg-RX-API-DMAC10.html)
CN (1) CN104812890A (cg-RX-API-DMAC10.html)
HK (1) HK1211980A1 (cg-RX-API-DMAC10.html)
IL (1) IL237339B (cg-RX-API-DMAC10.html)
IN (1) IN2015KN00516A (cg-RX-API-DMAC10.html)
WO (1) WO2014043637A1 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2988762T3 (en) * 2013-04-25 2018-07-16 Vaximm Ag SALMONELLA-BASED VECTORS FOR CANCER IMMUNITY TARGET TARGETED WILMS 'TUMORGEN WT1
PL3082850T3 (pl) 2013-12-18 2020-01-31 Vaximm Gmbh Celowana szczepionka DNA MSLN w immunoterapii nowotworu
CN105734001B (zh) * 2014-12-08 2020-04-07 中国人民解放军军事医学科学院生物工程研究所 一种o抗原糖链延长的甲型副伤寒沙门氏菌及其应用
IL256729B2 (en) * 2015-07-06 2023-03-01 Protein Potential Llc Live attenuated vaccine for oral administration against shigellosis and typhoid fever
GB201519734D0 (en) * 2015-11-09 2015-12-23 Univ Swansea Cancer therapy
CN106801029B (zh) * 2017-01-22 2020-05-01 山东大学 一株重组大肠杆菌及其在制备抗志贺氏菌的糖疫苗中的应用
MY190074A (en) * 2018-01-09 2022-03-24 Aimst Univ A monovalent vaccine formulation and a method for preparation thereof
CA3128507A1 (en) 2019-02-06 2020-08-13 Fred Hutchinson Cancer Research Center Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7541043B2 (en) * 2002-01-16 2009-06-02 The United States Of America As Represented By The Department Of Health And Human Services Vaccine for protection against Shigella sonnei disease
EP2657251B1 (en) 2004-05-24 2018-03-21 The Government of The United States of America, as represented by The Secretary, Department of Health and Human Services Live, oral vaccine for protection against Shigella dysenteriae serotype 1

Also Published As

Publication number Publication date
KR20150058435A (ko) 2015-05-28
US20150238591A1 (en) 2015-08-27
WO2014043637A1 (en) 2014-03-20
IL237339A0 (en) 2015-04-30
JP2015533491A (ja) 2015-11-26
IL237339B (en) 2019-06-30
US9750793B2 (en) 2017-09-05
CN104812890A (zh) 2015-07-29
EP2895596A1 (en) 2015-07-22
EP2895596A4 (en) 2016-07-27
IN2015KN00516A (cg-RX-API-DMAC10.html) 2015-07-17

Similar Documents

Publication Publication Date Title
CA3303669A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
IN2015KN00516A (cg-RX-API-DMAC10.html)
EP4494650A3 (en) Vaccine compositions having improved stability and immunogenicity
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
MX2013007657A (es) Oligodesoxinucleotidos inmunoestimulantes.
PH12015500956A1 (en) Novel mucosal adjuvants and delivery systems
EP2825196A4 (en) ADJUVANZ AND VACCINE COMPOSITIONS
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
EP3193919A4 (en) Immunogenic/therapeutic glycoconjugate compositions and uses thereof
MA46661A (fr) Formulations de vaccin glycoconjugué dirigé contre expec
EP3308800A4 (en) Adjuvant for vaccines, vaccine, and immunity induction method
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
MY189495A (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
EP3178491A4 (en) Composition for enhancing induction of humoral immunity, and vaccine pharmaceutical composition
HK1207152A1 (en) Multivalent breast cancer vaccine
PH12017501795B1 (en) Pestivirus vaccines for congenital tremors
ZA201706867B (en) Bordetella pertussis immunogenic vaccine compositions
IL251101B (en) Vaccine compounds comprising tryptophan 3,2-dioxygenase or fragments thereof
WO2012078051A3 (en) IPN Vaccine
EP2929894A4 (en) VACCINE ADJUVANS, PREPARATION AND VACCINES THEREOF
WO2012103444A3 (en) Immunogenic compositions and reagents for preparing
WO2010129457A3 (en) Vaccines against tularemia
HK1224187A1 (zh) 针对药物成瘾的疫苗组合物
EP3077512A4 (en) Immunogenic compositions and vaccines derived from bacterial surface receptor proteins
IL256729A (en) Live attenuated vaccine for oral administration against shigellosis and typhoid fever